IVF insurance gains attention as fertility costs rise

News desk: As infertility cases continue to rise globally and in Bangladesh, the high cost of treatment is pushing assisted reproductive technologies like in vitro fertilisation (IVF) out of reach for many couples. Industry experts say expanding insurance coverage for IVF could significantly improve access and outcomes.

IVF, one of the most widely used fertility treatments, involves a multi-step medical process that includes ovarian stimulation, egg retrieval, laboratory fertilisation and embryo transfer. A typical treatment cycle lasts around two to three weeks, although multiple cycles are often required for success.

Global fertility data suggests that IVF success rates vary significantly by age. Women under 35 have an average live birth rate of around 50 to 55 percent per cycle, while the rate drops to approximately 20 to 30 percent for those aged 38 to 40 and declines further beyond that age.

Despite its effectiveness, IVF remains prohibitively expensive for many. In the United States, a single cycle can cost between $12,000 and $30,000, excluding medications and additional procedures. In Europe, costs are lower but still substantial, often reaching several thousand euros per cycle.

‘Cost remains one of the biggest barriers to fertility care,’ said a fertility specialist, adding that many patients are forced to delay or abandon treatment due to financial constraints.

Insurance coverage has emerged as a critical factor in addressing this challenge. In countries where IVF is partially or fully covered, patients are more likely to complete recommended treatment cycles and opt for safer medical practices, such as transferring fewer embryos to reduce the risk of multiple pregnancies.

In the United States, only a limited number of states mandate infertility coverage and comprehensive IVF benefits are often subject to restrictions such as cycle limits or lifetime caps. Major insurers offer varying levels of support, ranging from diagnostic services to partial treatment coverage.

European countries generally provide broader support through public healthcare systems. For example, in the Netherlands, basic health insurance typically covers up to three IVF or intracytoplasmic sperm injection (ICSI) cycles for medically indicated cases, subject to eligibility criteria and age limits.

However, in Bangladesh, IVF treatment remains almost entirely financed out-of-pocket. While several private clinics offer advanced fertility services, no insurance provider currently includes IVF coverage in standard health policies.

Healthcare analysts say this gap reflects broader challenges in the country’s insurance sector, including limited product innovation and low health insurance penetration.

‘Introducing IVF coverage could be a game-changer, not just for patients but for the insurance industry as well,’ said an industry observer. ‘It would address a growing healthcare need while expanding the scope of health insurance in Bangladesh.’

As awareness of fertility issues increases and demand for treatment grows, experts believe insurers and employers may eventually explore fertility benefits as part of broader healthcare offerings.

For thousands of couples struggling with infertility, the expansion of IVF insurance could mean the difference between prolonged uncertainty and a realistic chance at starting a family.